GlassScriptPhysician profile
Cynthia M Rice
NPI 1427041763
$2,995.23
in general payments reported to CMS, 2019-2025
17 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $700 · 2022: $493 · 2023: $749 · 2024: $675 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Education: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.03 |
| Education | $289.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $789.02 | 2021-2025 | |
| Inspire Medical Systems, INC. | $383.97 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $318.44 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $279.16 | 2021-2025 | |
| Novo Nordisk INC | $259.53 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $254.46 | 2021-2023 | Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $147.53 | 2022-2025 | Caplyta |
| Axsome Therapeutics, INC. | $145.43 | 2023-2025 | Sunosi |
| Lilly USA, LLC | $109.93 | 2021-2025 | Zepbound |
| Teva Pharmaceuticals USA, INC. | $108.57 | 2022-2023 | |
| Zoll Respicardia, INC. | $53.66 | 2023 | Remede System |
| Eisai INC. | $45.09 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.34 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $29.09 | 2021 | |
| Itamar Medical INC | $16.73 | 2023 | Watchpatone |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $12.16 | 2022 | |
| Amgen INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.